Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | -9.55% | |
| Upper Bollinger Band Walk | Strength | -9.55% | |
| Earnings Movers | Other | -9.55% | |
| Inside Day | Range Contraction | -9.55% | |
| Overbought Stochastic | Strength | -9.55% | |
| Upper Bollinger Band Touch | Strength | -9.55% | |
| Bearish Engulfing | Bearish | -7.48% | |
| Upper Bollinger Band Walk | Strength | -7.48% | |
| Outside Day | Range Expansion | -7.48% | |
| Gapped Up | Strength | -7.48% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 26 minutes ago |
| Down 10% | 26 minutes ago |
| Upper Bollinger Band Resistance | about 5 hours ago |
| Reversed from Down | about 5 hours ago |
| 60 Minute Opening Range Breakout | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.12 |
| 52 Week Low | 0.5902 |
| Average Volume | 990,555 |
| 200-Day Moving Average | 3.44 |
| 50-Day Moving Average | 1.23 |
| 20-Day Moving Average | 1.24 |
| 10-Day Moving Average | 1.26 |
| Average True Range | 0.07 |
| RSI (14) | 62.69 |
| ADX | 20.35 |
| +DI | 23.87 |
| -DI | 13.07 |
| Chandelier Exit (Long, 3 ATRs) | 1.18 |
| Chandelier Exit (Short, 3 ATRs) | 1.36 |
| Upper Bollinger Bands | 1.34 |
| Lower Bollinger Band | 1.13 |
| Percent B (%b) | 0.99 |
| BandWidth | 16.92 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.01 |
| MACD Histogram | 0.0151 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.46 | ||||
| Resistance 3 (R3) | 1.45 | 1.41 | 1.44 | ||
| Resistance 2 (R2) | 1.41 | 1.38 | 1.41 | 1.43 | |
| Resistance 1 (R1) | 1.37 | 1.36 | 1.39 | 1.38 | 1.43 |
| Pivot Point | 1.33 | 1.33 | 1.34 | 1.33 | 1.33 |
| Support 1 (S1) | 1.29 | 1.30 | 1.31 | 1.30 | 1.25 |
| Support 2 (S2) | 1.25 | 1.28 | 1.25 | 1.25 | |
| Support 3 (S3) | 1.21 | 1.25 | 1.24 | ||
| Support 4 (S4) | 1.22 |
